Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under PDS Biotechnology Corporation in our court records and SEC 8-K records (as of 2026-10-18).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-08-25).
- Leadership changes: the latest reported is James Banaag, Director (Form 8-K filed 2026-09-14). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Nant Capital, LLC (filed 2026-09-21).
Who is behind it
PDS Biotechnology Corp: incorporated in Delaware; business address in Princeton, New Jersey; industry Pharmaceutical Preparations (Schedule 13D, 2026-09-21).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-09-21 | Nant Capital, LLC | 19.9% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 4.99% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-14 | James Banaag | Director | appointed | |
| Form 8-K, 2026-08-19 | Janetta Trochimiuk | President and Chief Executive Officer | appointed | 2026-09-12 |
Money raised
Latest IPO step: PDS Biotechnology Corp filed its final IPO prospectus (424B4, 2026-07-21).
IPO filings: 424B4, 2026-07-21.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-08-25).
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/pds-biotechnologyLast updated 2026-10-18
Primary record: Schedule 13D, 2026-09-21 · Form 8-K, 2026-09-14 · Form 8-K, 2026-08-19 · 424B4, 2026-07-21
Who owns PDS Biotechnology Corp? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/pds-biotechnology